Literature DB >> 29033351

Mouse Cutaneous Melanoma Induced by Mutant BRaf Arises from Expansion and Dedifferentiation of Mature Pigmented Melanocytes.

Corinna Köhler1, David Nittner1, Florian Rambow1, Enrico Radaelli2, Fabio Stanchi3, Niels Vandamme4, Arianna Baggiolini5, Lukas Sommer5, Geert Berx4, Joost J van den Oord6, Holger Gerhardt3, Cedric Blanpain7, Jean-Christophe Marine8.   

Abstract

To identify the cells at the origin of melanoma, we combined single-cell lineage-tracing and transcriptomics approaches with time-lapse imaging. A mouse model that recapitulates key histopathological features of human melanomagenesis was created by inducing a BRafV600E-driven melanomagenic program in tail interfollicular melanocytes. Most targeted mature, melanin-producing melanocytes expanded clonally within the epidermis before losing their differentiated features through transcriptional reprogramming and eventually invading the dermis. Tumors did not form within interscales, which contain both mature and dormant amelanotic melanocytes. The hair follicle bulge, which contains melanocyte stem cells, was also refractory to melanomagenesis. These studies identify varying tumor susceptibilities within the melanocytic lineage, highlighting pigment-producing cells as the melanoma cell of origin, and indicate that regional variation in tumor predisposition is dictated by microenvironmental cues rather than intrinsic differences in cellular origin. Critically, this work provides in vivo evidence that differentiated somatic cells can be reprogrammed into cancer initiating cells.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cell of origin; cutaneous melanoma; lineage tracing; mouse model; single-cell transcriptomics; time-lapse imaging

Mesh:

Substances:

Year:  2017        PMID: 29033351     DOI: 10.1016/j.stem.2017.08.003

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  34 in total

1.  Loss of prdm1a accelerates melanoma onset and progression.

Authors:  Ritsuko Iwanaga; Brittany T Truong; Jessica Y Hsu; Karoline A Lambert; Rajesh Vyas; David Orlicky; Yiqun G Shellman; Aik-Choon Tan; Craig Ceol; Kristin Bruk Artinger
Journal:  Mol Carcinog       Date:  2020-06-20       Impact factor: 4.784

Review 2.  Cancer stem cells: a major culprit of intra-tumor heterogeneity.

Authors:  Faiza Naz; Mengran Shi; Salvia Sajid; Zhao Yang; Changyuan Yu
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

3.  Cell position matters in tumour development.

Authors:  Jean-Christophe Marine; María S Soengas
Journal:  Nature       Date:  2022-04       Impact factor: 49.962

Review 4.  Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Med Sci (Basel)       Date:  2017-11-20

5.  Cancer Cells Retrace a Stepwise Differentiation Program during Malignant Progression.

Authors:  Sadegh Saghafinia; Iacovos P Michael; Krisztian Homicsko; Annunziata Di Domenico; Stephan Wullschleger; Aurel Perren; Ilaria Marinoni; Giovanni Ciriello; Douglas Hanahan
Journal:  Cancer Discov       Date:  2021-04-28       Impact factor: 39.397

Review 6.  Melanoma models for the next generation of therapies.

Authors:  E Elizabeth Patton; Kristen L Mueller; David J Adams; Niroshana Anandasabapathy; Andrew E Aplin; Corine Bertolotto; Marcus Bosenberg; Craig J Ceol; Christin E Burd; Ping Chi; Meenhard Herlyn; Sheri L Holmen; Florian A Karreth; Charles K Kaufman; Shaheen Khan; Sebastian Kobold; Eleonora Leucci; Carmit Levy; David B Lombard; Amanda W Lund; Kerrie L Marie; Jean-Christophe Marine; Richard Marais; Martin McMahon; Carla Daniela Robles-Espinoza; Ze'ev A Ronai; Yardena Samuels; Maria S Soengas; Jessie Villanueva; Ashani T Weeraratna; Richard M White; Iwei Yeh; Jiyue Zhu; Leonard I Zon; Marc S Hurlbert; Glenn Merlino
Journal:  Cancer Cell       Date:  2021-02-04       Impact factor: 31.743

7.  Model-dependent outcomes: Sex as a biological variable in preclinical mouse models of melanoma.

Authors:  Gennie L Parkman; David A Kircher; Christopher M Stehn; Martin McMahon; Sheri L Holmen
Journal:  Pigment Cell Melanoma Res       Date:  2020-11-11       Impact factor: 4.693

8.  Classification and Grading of Melanocytic Lesions in a Mouse Model of NRAS-driven Melanomagenesis.

Authors:  Charles-Antoine Assenmacher; Sara F Santagostino; Mark A Oyama; Jean-Christophe Marine; Elise Bonvin; Enrico Radaelli
Journal:  J Histochem Cytochem       Date:  2020-12-07       Impact factor: 2.479

9.  Loss of Ambra1 promotes melanoma growth and invasion.

Authors:  Luca Di Leo; Valérie Bodemeyer; Francesca M Bosisio; Giuseppina Claps; Marco Carretta; Salvatore Rizza; Fiorella Faienza; Alex Frias; Shawez Khan; Matteo Bordi; Maria P Pacheco; Julie Di Martino; Jose J Bravo-Cordero; Colin J Daniel; Rosalie C Sears; Marco Donia; Daniel H Madsen; Per Guldberg; Giuseppe Filomeni; Thomas Sauter; Caroline Robert; Daniela De Zio; Francesco Cecconi
Journal:  Nat Commun       Date:  2021-05-05       Impact factor: 14.919

10.  PERK mediates resistance to BRAF inhibition in melanoma with impaired PTEN.

Authors:  Yifei Qin; Qiang Zuo; Lei Huang; Liping Huang; Glenn Merlino; Yanlin Yu
Journal:  NPJ Precis Oncol       Date:  2021-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.